文拉法新与阿普唑仑治疗广泛性焦虑症的对照研究
Comparison of Veniafaxine and Alprazolam in the treatment of generalized anxiety disorder
作者:李进,况伟宏,王雪,朱昌明
Author:
收稿日期: 年卷(期)页码:2004,(02):-150-152
期刊名称:华西药学杂志
Journal Name:WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字:广泛性焦虑;文拉法新;阿普唑仑
Key words:
基金项目:
中文摘要
目的 比较文拉法新与阿普唑仑治疗广泛性焦虑症的疗效及不良反应。方法 符合CCMD-3诊断标准的广泛性焦虑症病例50例,随机分为文拉法新组(26例)和阿普唑仑组(24例)。分别用文拉法新50~175mg·d-1,阿普唑仑0.8-2.4mg·d-1,治疗观察12周。用汉密尔顿焦虑量表(HAMA)和药物副反应量表(TESS),评定疗效和药物不良反应。结果 文拉法新与阿普唑仑疗效相当,起效时间相当,文拉法新的中长期疗效更佳,无严重不良反应及药物依赖性。结论 文拉法新治疗广泛性焦虑症疗效好,起效较快、副反应轻,患者服药依从性好。
参考文献
[1] Connor KM, Davidson JRT.The neurobiology of generalized anxietydisorder[J]. Biol Psychiatry, 1998,44:1284
[2] Davidson JRT, Dupont RL, Hedges D, et al. Efficacy, safety, and tol-erability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder[J]. J Clin Psychiatry, 1999,60:528
[3] Montgomery SA, Mahe V, Hackett D. Effectiveness of venlafaxine, extended releaseformulation in the short-term and long-term treat- ment of generalized anxiety disorder: results of a survival analysis[J] . J Clin Psyehopharmacol,2002,22(6) :561
[4] Gorman JM.Treatment of generalized anxiety disorder[J].J Clin Psy- chiatry, 2002,63(8) :17
【关闭】